Extended sleep improved sleep metrics but did not change insulin sensitivity in a small trial.

The trial examined the impact of extended sleep versus habitual sleep on metabolic parameters in individuals with overweight, obesity, insulin resistance, and short sleep schedules. Participants in the extended sleep group spent more time in bed and achieved greater increases in sleep duration compared to the control group. Subjective measures of sleep health and day-to-day variability in sleep also improved more in the extended sleep group.

Despite these improvements in sleep metrics, the study observed no differences between groups regarding multiorgan insulin sensitivity or glycemic control. The primary outcome of interest, which included hepatic and adipose tissue insulin sensitivity, showed no benefit from the intervention. Secondary outcomes related to blood sugar regulation similarly failed to show a significant advantage for the extended sleep approach.

The authors note that the small number of participants and the brief duration of the study limit the ability to draw firm conclusions. Safety was not a primary focus as adverse events were not reported. Clinicians should interpret these results with caution, recognizing that extended sleep may improve sleep quality without necessarily resolving underlying metabolic dysfunction in this specific population.